Cargando…
PHLPP2 as a novel metastatic and prognostic biomarker in non‐small cell lung cancer patients
BACKGROUND: PH domain and leucine‐rich repeat protein phosphatase 2 (PHLPP2) has been reported to be a potent tumor suppressor in many human cancers. However, PHLPP2 has not been fully researched as a putative clinical prognostic biomarker of lung cancer. METHODS: The Cancer Genome Atlas (TCGA) and...
Autores principales: | Wang, Hongmei, Gu, Ruixue, Tian, Fanglin, Liu, Yuechao, Fan, Weina, Xue, Guiqin, Cai, Li, Xing, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825916/ https://www.ncbi.nlm.nih.gov/pubmed/31571378 http://dx.doi.org/10.1111/1759-7714.13196 |
Ejemplares similares
-
LINC02678 as a Novel Prognostic Marker Promotes Aggressive Non-small-cell Lung Cancer
por: Jia, Dexin, et al.
Publicado: (2021) -
Identification of Differentially Expressed and Prognostic lncRNAs for the Construction of ceRNA Networks in Lung Adenocarcinoma
por: Cui, Yimeng, et al.
Publicado: (2021) -
LRH1 as a promising prognostic biomarker and predictor of metastasis in patients with non‐small cell lung cancer
por: Liu, Yuechao, et al.
Publicado: (2018) -
A novel EHD1/CD44/Hippo/SP1 positive feedback loop potentiates stemness and metastasis in lung adenocarcinoma
por: Liu, Yuechao, et al.
Publicado: (2022) -
PHLPP2: A Prognostic Biomarker in Adenocarcinoma of the Rectum
por: Xie, Keju
Publicado: (2023)